Drug Database
Back to search

Belgium· BE-AMP-SAM185464-00

Neo-Cutigenol 0.7 g/100 g - 400000 IU/100 g

A chlorhexidin, kombinationen product containing retinol palmitate, registered in Belgium by Takeda Belgium. The same ATC class is registered in 9 of our 19 countries.

ATC D08AC52

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedNeo-Cutigenol 0.7 g/100 g - 400000 IU…ATCD08AC52REGISTER NO.BE-AMP-SAM185464-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about retinol palmitateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chlorhexidin, kombinationen is registered in 9 of 19 countries.

Countries holding a registration under ATC D08AC52 (chlorhexidin, kombinationen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search chlorhexidin, kombinationen products by name

Chlorhexidin, kombinationen · ATC D08AC52

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Retinol Palmitate
Manufacturer
Takeda Belgium
Country
Belgium (BE)
ATC code
D08AC52
ATC class
Chlorhexidin, Kombinationen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    0052589
  • be_apb
    0052613
  • be_apb
    2881019

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Chlorhexidin, kombinationen in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorhexidin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Germany · Vitadral Tropfen
  • Spain · Rinocusi Vitamínico
  • France · Vitamine A Provepharm
  • Greece · Milpaton-A
  • Hungary · Vitamin A Bioextra
  • Poland · Aksoderm, Aksoderm Forte
  • Portugal · Vitaminoftalmina A
  • Romania · Vitamina A Biofarm, Vitamina A Forte Biofarm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/13cbd75b-b67e-4a0d-9f2d-b529f58346b0
GET /v1/drugs/13cbd75b-b67e-4a0d-9f2d-b529f58346b0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Ointment",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Neo-Cutigenol 0.7 g/100 g - 400000 IU/100 g",
  "name_fr": "Neo-Cutigenol 0.7 g/100 g - 400000 IU/100 g",
  "name_nl": "Neo-Cutigenol 0.7 g/100 g - 400000 IU/100 g",
  "amp_code": "SAM185464-00",
  "strengths": [
    "400000.0000",
    "400000.0000",
    "0.7000",
    "0.7000",
    "35.0000",
    "35.0000",
    "27.7000"
  ],
  "pack_count": 3,
  "substances": [
    "Retinol Palmitate",
    "Chlorhexidine Diacetate",
    "Butylhydroxyanisole",
    "Butylhydroxytoluene",
    "Wool Fat"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Chlorhexidine, Combinations",
  "authorisation_numbers": [
    "BE185464"
  ]
}
API referenceMCP serverPlans

See everything about chlorhexidin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console